GHSI - Guardion Health Sciences Inc Stock Price, Fair Value and News

$3.220.00 (0.00%)

Market Closed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

GHSI Price Action

Last 30 days

-1.2%

Last 90 days

-64.2%

Trailing 12 Months

-38.3%

GHSI RSI Chart

GHSI Valuation

Market Cap

4.1M

Price/Earnings (Trailing)

0.65

Price/Sales (Trailing)

0.34

Price/Free Cashflow

-1.06

GHSI Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

GHSI Fundamentals

GHSI Revenue

Revenue (TTM)

12.2M

Rev. Growth (Yr)

-5.84%

Rev. Growth (Qtr)

2.17%

GHSI Earnings

Earnings (TTM)

6.4M

Earnings Growth (Yr)

980.61%

Earnings Growth (Qtr)

317.5%

GHSI Profitability

Return on Equity

46.36%

Return on Assets

41.67%

Free Cashflow Yield

-94.78%

GHSI Investor Care

Shares Dilution (1Y)

0.85%

Diluted EPS (TTM)

4.87

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	0	0	0	0
2023	11.9M	12.0M	12.1M	12.2M
2022	9.4M	11.4M	11.0M	11.0M
2021	1.9M	1.9M	4.8M	7.2M
2020	906.1K	1.8M	1.9M	1.9M
2019	991.7K	1.0M	898.8K	902.9K
2018	574.5K	735.3K	966.8K	942.2K
2017	167.8K	198.4K	227.4K	437.4K
2016	119.9K	126.9K	134.0K	141.0K
2015	0	0	0	112.8K

Get all data in R, Python etc through our Historical Stock Data APIs

About Guardion Health Sciences Inc

Guardion Health Sciences, Inc., a clinical nutrition company, develops and distributes clinically supported nutrition, medical foods, and dietary supplements in North America and Europe, and Internationally. The company offers Lumega-Z, a medical food that replenishes and restores the macular protective pigment; and GlaucoCetin, a vision-specific medical food to support and protect the mitochondrial function of optic nerve cells, as well as improve blood flow in the ophthalmic artery in patients with glaucoma. It develops ImmuneSF, a nutraceutical formulation, as well as a portfolio of nutraceutical products under the NutriGuard brand. Further, it distributes medical foods products through e-commerce in an online store, guardionhealth.com. Guardion Health Sciences, Inc. was founded in 2009 and is headquartered in Houston, California.

CEO	Ms. Janet Hall
WEBSITE	guardionhealth.com
SECTOR	Healthcare
INDUSTRY	Drug Manufacturers Specialty & Generic
EMPLOYEES	12

Guardion Health Sciences Inc Frequently Asked Questions

What is the ticker symbol for Guardion Health Sciences Inc? What does GHSI stand for in stocks?

GHSI is the stock ticker symbol of Guardion Health Sciences Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Guardion Health Sciences Inc (GHSI)?

As of Tue Nov 19 2024, market cap of Guardion Health Sciences Inc is 4.13 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of GHSI stock?

You can check GHSI's fair value in chart for subscribers.

Is Guardion Health Sciences Inc a good stock to buy?

The fair value guage provides a quick view whether GHSI is over valued or under valued. Whether Guardion Health Sciences Inc is cheap or expensive depends on the assumptions which impact Guardion Health Sciences Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for GHSI.

What is Guardion Health Sciences Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Tue Nov 19 2024, GHSI's PE ratio (Price to Earnings) is 0.65 and Price to Sales (PS) ratio is 0.34. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. GHSI PE ratio will change depending on the future growth rate expectations of investors.